Maryam Rafati, MD, PhD^1*, Derek W Brown^1*, Weiyin Zhou^1*, Kristine Jones^1,2*, Wen Luo^3,4*, Andrew St. Martin, MS^5*, Youjin Wang, PhD, BPharm^1*, Stephen R. Spellman^6*, Tao Wang, PhD^5,7*, H. Joachim Deeg, MD⁸, Vikas Gupta, MD, FRCP, FRCPath⁹, Stephanie J. Lee, MD, MPH^10,11, Stephen J. Chanock, MD^1*, Mitchell Machiela, PhD^1*, Wael Saber, MD, MS⁵ and Shahinaz M. Gadalla, MD, PhD¹²

¹Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
²Cancer Genomics Research Laboratory, Frederick National Laboratory, Frederick, MD
³Division of Cancer Epidemiology and Genetics,, National Cancer Institute, Rockville, MD
⁴Frederick National Laboratory for Cancer Research, Frederick, MD
⁵CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁶CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
⁷Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
¹⁰CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match®, Medical College of Wisconsin, Milwaukee, WI
¹¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹²Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD

Muhammad Bilal Abid, MD, MS, MRCP, FRCP^1*, Noel Estrada-Merly, MS^1*, Mei-Jie Zhang, PhD^1,2*, Karen Chen, MS^1*, David S. Allan, MD, FRCPC, MSc³, Christopher Bredeson, MD, MSc, FRCPC^3*, Mitchell Sabloff, MSc, MD, FRCPC³, Mark R. Litzow, MD⁴, Partow Kebriaei, MD⁵ and Wael Saber, MD, MS¹

¹CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
⁴Mayo Clinic, Rochester, MN
⁵Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Mallory Taylor, MD^1*, Steve W. Cole, PhD^2*, Joelle Strom, MS^3*, Ruta Brazauskas, PhD^4*, K. Scott Baker, MD, MS⁵, Rachel Phelan, MD, MPH^6,7, David K. Buchbinder, MD, MSHS⁸, Betty K. Hamilton, MD⁹, Helene Schoemans, MD^10* and Jennifer M Knight, MD MS^11,12,13*

¹Palliative Care and Resilience Program, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA
²Departments of Psychiatry & Biobehavioral Sciences and Medicine, UCLA School of Medicine, Los Angeles, CA
³CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Division of Biostatistics. Institute for Heath and Equity, Medical College of Wisconsin, Milwaukee, WI
⁵Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁶Division of Hematology and Oncology- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
⁷CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
⁸Department of Hematology, Children's Hospital of Orange County, Orange, CA
⁹Cleveland Clinic Foundation, Cleveland, OH
¹⁰Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, Leuven, Belgium
¹¹Department of Psychiatry and Departments of Medicine and Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI
¹²Section of BMT & Cellular Therapies; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹³Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI

Ghayas C. Issa, MD¹, Branko Cuglievan, MD^2*, Eytan Stein, MD³, Martha L. Arellano, MD⁴, Andrius Zucenka, MD^5*, Nandita Khera, MD, MPH⁶, Richard M. Stone, MD⁷, Michael J. Thirman, MD⁸, John F. DiPersio, MD, PhD⁹, Nicole Karras, MD^10*, Yu Gu, PhD^11*, Rebecca G. Bagley, MA^11*, Galit Rosen, MD¹¹, David Tamang^11*, Kimberly Dishman, NP^11*, Sushama Scalera, MD^11*, Michael L. Meyers, MD, PhD^11*, Kate Madigan, MD^11*, Nicole McNeer, MD, PhD¹¹ and Ibrahim Aldoss, MD¹²

¹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
²Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁵Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
⁶Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
⁷Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁹Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
¹⁰Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
¹¹Syndax Pharmaceuticals, Inc., Waltham, MA
¹²City of Hope, Duarte, CA

Jacqueline S. Garcia, MD¹, Haesook T Kim, PhD¹, Jennifer Brock^2*, H. Moses Murdock, MD², Corey S. Cutler, MD, MPH, FRCPC^3*, Daniel J. DeAngelo, MD, PhD^2*, Christopher J. Gibson, MD¹, Mahasweta Gooptu, MD², Vincent Ho, MD^4*, John Koreth, MBBS, DPhil⁵, Marlise R. Luskin, MD¹, Sarah Nikiforow, MD, PhD^1*, Rizwan Romee, MD⁶, Roman M Shapiro, MD⁷, Richard M. Stone, MD⁸, Martha Wadleigh, MD^9*, Eric S. Winer, MD¹, Michela Ansuinelli^4*, Eliza Elliot^4*, Geoffrey Fell^4*, Hannah Karp^4*, Jeremy Ryan^1*, Anthony G. Letai, MD, PhD¹, Coleman Lindsley, MD, PhD¹, Robert J Soiffer, MD¹⁰, Joseph H. Antin, MD¹¹, Fiona Loschi^4* and Jerome Ritz, MD, PhD⁵

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber Cancer Institute, Boston
⁵Dana-Farber Cancer Institute, Division of Hematologic Malignancies and Harvard Medical School, Boston, MA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Jamaica Plain, MA
⁸Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
¹⁰Division of Stem Cell Transplant and Cellular Therapies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Emily C. Liang, MD^1,2, Lynn E. Onstad, ScM^1*, Paul A. Carpenter, MD^1,3, Steven A. Pergam, MD, MPH^1,2,4*, Stephanie J. Lee, MD, MPH^1,2 and Catherine Liu, MD^1,2,4*

¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²Department of Medicine, University of Washington, Seattle, WA
³Department of Pediatrics, University of Washington, Seattle, WA
⁴Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA